1. Home
  2. RCUS vs FBK Comparison

RCUS vs FBK Comparison

Compare RCUS & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$22.22

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo FB Financial Corporation

FBK

FB Financial Corporation

HOLD

Current Price

$51.65

Market Cap

3.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
FBK
Founded
2015
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
RCUS
FBK
Price
$22.22
$51.65
Analyst Decision
Buy
Buy
Analyst Count
10
4
Target Price
$29.20
$61.75
AVG Volume (30 Days)
1.1M
209.6K
Earning Date
05-28-2026
04-22-2026
Dividend Yield
N/A
1.58%
EPS Growth
N/A
N/A
EPS
N/A
2.45
Revenue
$247,000,000.00
N/A
Revenue This Year
N/A
$43.54
Revenue Next Year
$57.34
$7.86
P/E Ratio
N/A
$21.78
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$38.83
52 Week High
$26.40
$62.37

Technical Indicators

Market Signals
Indicator
RCUS
FBK
Relative Strength Index (RSI) 54.67 27.56
Support Level $20.35 $42.58
Resistance Level $24.16 $55.81
Average True Range (ATR) 1.28 1.75
MACD 0.38 -0.70
Stochastic Oscillator 57.99 11.69

Price Performance

Historical Comparison
RCUS
FBK

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About FBK FB Financial Corporation

FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.

Share on Social Networks: